| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
CytoSorbents (NASDAQ:CTSO) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:15 PM.
Here's what investors need to know about the announcement.
CytoSorbents beat estimated earnings by 14.000000000000002%, reporting an EPS of $-0.12 versus an estimate of $-0.14.
Revenue was down $691 thousand from the same period last year.
Last quarter the company missed on EPS by $0.09 which was followed by a 1.0% increase in the share price the next day.
Here's a look at CytoSorbents's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.12 | -0.11 | -0.13 | -0.17 |
| EPS Actual | -0.21 | -0.14 | -0.17 | -0.01 |
| Revenue Estimate | 9.49M | 11.03M | 8.73M | 8.72M |
| Revenue Actual | 8.81M | 9.42M | 9.45M | 9.39M |
To track all earnings releases for CytoSorbents visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CTSO
